Results 111 to 120 of about 631,704 (344)
Chaos, Solitons & Fractals, 2005 Several corrections of typos and smaller revisions, final ...
openaire +4 more sources
Annals of Clinical and Translational Neurology, EarlyView.Epigenetic reprogramming in hematopoietic stem and progenitor cells (HSPCs) and downstream myeloid cells, mediated by H3.3 downregulation and endogenous retroelement (ERE) overexpression, contributes to the progression of multiple sclerosis (MS). ABSTRACT Background Skewed myelopoiesis in the bone marrow has been identified as a key driver of multiple ...
Li‐Mei Xiao +6 more
wiley +1 more source
Impact of Family Non-universal $Z^\prime$ Boson on Pure Annihilation $B_s \to π^+ π^-$ and $B_d \to K^+ K^-$ Decays [PDF]
, 2015 Ying Li +4 more
openalex +1 more source
Fundamenta Mathematicae, 2014 A function of two variables F(x,y)is universal iff for every other function G(x,y) there exists functions h(x) and k(y) with G(x,y) = F(h(x),k(y)) Sierpinski showed that assuming the continuum hypothesis there exists a Borel function F(x,y) which is universal. Assuming Martin's Axiom there is a universal function of Baire class 2.
Larson, Paul B. +3 more
openaire +2 more sources
Sex Representation in US Stroke Clinical Trials: A Decade of Trends and Challenges
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Stroke remains a major cause of disability and mortality in the US, with significant sex‐based disparities, and females remain underrepresented in stroke clinical trials. We aimed to examine sex representation in US‐based stroke clinical trials, identify trial characteristics associated with higher female enrollment (≥ 50%), and ...
Chaitali Dagli +5 more
wiley +1 more source
Pulmonary Function Prediction Equations—Clinical Ramifications of a Universal Standard [PDF]
, 2023 Adam Gaffney
openalex +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source
ALDOA Promotes Glycolysis and NLRP3/GSDMD Pyroptosis to Accelerate ALS Progression
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Amyotrophic lateral sclerosis (ALS) is characterized by progressive motor neuron degeneration. Glycolytic dysregulation is implicated in disease progression, yet the underlying mechanisms remain unclear. This study investigates how Aldolase A (ALDOA) drives ALS progression through glycolysis‐mediated motor neuron pyroptosis.
Kaixin Yan +9 more
wiley +1 more source
Acyclic anyon models, thermal anyon error corrections, and braiding universality [PDF]
, 2018 César Galíndo +2 more
openalex +1 more source